Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?

‘Old’ colistin and polymyxin B are increasingly used as last-line therapy against multidrug-resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae. For intravenous administration, colistin is dosed as its inactive prodrug colistin methanesulfonate...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bergen, Phillip J., Landersdorfer, Cornelia B., Zhang, Jing, Zhao, Miao, Lee, Hee Ji, Nation, Roger L., Li, Jian
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3477253/
https://ncbi.nlm.nih.gov/pubmed/22959816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.diagmicrobio.2012.07.010
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky